ITM Receives FDA Complete Response Letter for ITM-11
Garching/Munich, Germany and Princeton, New Jersey, August 10, 2026 ITM Isotope Technologies Munich SE (ITM) announced that the U.S....
CMC
Advertisement
NRx Pharmaceuticals Clears FDA ANDA Review
MIAMI, August 7, 2026 NRx Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has completed the first-cycle...
NueCell Bio Launches GMP Cell Therapy Development Platform
San Diego, California, August 5, 2026 NueCell Bio has officially launched as a specialized cell therapy science and development...
Insilico Medicine Partners Bora for AI Drug Innovation
HONG KONG & TAIPEI, Taiwan, July 14, 2026 Insilico Medicine and Bora Pharmaceuticals Co., Ltd. have announced a landmark...
Sobi Receives FDA Complete Response Letter for NASP BLA
STOCKHOLM, Sweden, June 26, 2026 Sobi announced that it has received a Complete Response Letter (CRL) from the U.S....
Advertisements
NurExone Strengthens GMP Exosome Supply via BioXtek
TORONTO, Canada; HAIFA, Israel; and POMPANO BEACH, Florida, April 7, 2026 NurExone Biologic Inc. announced that its U.S. subsidiary...
Marvel Secures Funding for Pediatric Liquid MB-204
Child-Friendly MB-204 Formulation Targets Neuro Disorders – February 18, 2026 | Calgary, Alberta Marvel Biosciences Corp. has secured advisory...
Twist Bioscience Unveils Plasmid Preps to Fuel Nucleic-Acid Therapeutics Research
San Francisco, CA – December 4, 2025 — Twist Bioscience today announced the launch of a new line of...
Lifordi Gains Major Investment to Advance ADC Autoimmune Therapy
Dateline Introduction Burlington, Massachusetts — November 18, 2025 — Lifordi Immunotherapeutics has announced a strategic investment from Sanofi Ventures,...
Advertisement
